Macquarie Group
BLFS icon

Macquarie Group’s BioLife Solutions BLFS Stock Holding History

Macquarie Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
+8,719
New +$204K ﹤0.01% 775
2025
Q4 		– Sell
-101,676
Closed -$2.59M – 941
2025
Q3 		$2.59M Sell
101,676
-2,001
-2% -$47.5K ﹤0.01% 1102
2025
Q2 		$2.23M Sell
103,677
-1,262
-1% -$28.4K ﹤0.01% 1188
2025
Q1 		$2.4M Sell
104,939
-2,426
-2% -$63.9K ﹤0.01% 1168
2024
Q4 		$2.79M Buy
107,365
+12,240
+13% +$305K ﹤0.01% 1088
2024
Q3 		$2.38M Buy
95,125
+650
+0.7% +$15.4K ﹤0.01% 1177
2024
Q2 		$2.02M Sell
94,475
-109
-0.1% -$2.12K ﹤0.01% 1218
2024
Q1 		$1.75M Sell
94,584
-1,649
-2% -$28.8K ﹤0.01% 1262
2023
Q4 		$1.56M Buy
96,233
+13,995
+17% +$179K ﹤0.01% 1289
2023
Q3 		$1.14M Buy
82,238
+1,604
+2% +$25.3K ﹤0.01% 1317
2023
Q2 		$1.78M Buy
80,634
+12,317
+18% +$259K ﹤0.01% 1212
2023
Q1 		$1.49M Buy
68,317
+12,644
+23% +$284K ﹤0.01% 1254
2022
Q4 		$1.01M Sell
55,673
-18,728
-25% -$387K ﹤0.01% 1412
2022
Q3 		$1.7M Buy
74,401
+964
+1% +$20.6K ﹤0.01% 1280
2022
Q2 		$1.01M Buy
73,437
+766
+1% +$11.2K ﹤0.01% 1477
2022
Q1 		$1.65M Buy
72,671
+2,307
+3% +$60.7K ﹤0.01% 1419
2021
Q4 		$2.62M Buy
70,364
+69,769
+11,726% +$2.99M ﹤0.01% 1292
2021
Q3 		$25K Hold
595
– – ﹤0.01% 2400
2021
Q2 		$26K Buy
+595
New +$21K ﹤0.01% 2305
2018
Q4 		– Sell
-600
Closed -$10K – 2253
2018
Q3 		$10K Sell
600
-7,100
-92% -$140K ﹤0.01% 1994
2018
Q2 		$88K Buy
+7,700
New +$70.1K ﹤0.01% 1867
2018
Q1 		– Sell
-5,600
Closed -$34K – 2191
2017
Q4 		$34K Buy
+5,600
New +$32.3K ﹤0.01% 2057

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macquarie Group's BLFS Position: Q2 2026 in Review

Macquarie Group opened a new position in BioLife Solutions (BLFS) in Q2 2026: 8,719 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #775 among its holdings. This is a return to the name: Macquarie Group previously reported a position in BLFS as recently as Q3 2025.

Macquarie Group first reported a position in BLFS in Q4 2017 and has held it in 22 quarters since. The position peaked at $2.79M in Q4 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Macquarie Group held 8,719 shares of BioLife Solutions worth $246K as of Q2 2026.
  • BioLife Solutions was a new Macquarie Group position in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #775 holding.
  • Macquarie Group first reported a position in BioLife Solutions in Q4 2017 and has held it in 22 quarters since.
  • Macquarie Group's BioLife Solutions position peaked at $2.79M in Q4 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.